This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB01444/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01444/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01444/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://linked.opendata.cz/resource/drugbank/drug/DB01444/identifier/chemspider/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB01444/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01444/identifier/wikipedia/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01444
rdf:type
n3:Drug
n3:description
Dimethylthiambutene (N,N-Dimethyl-1-methyl-3,3-di-2-thienylallylamine, Dimethibutin, Ohton) is an opioid analgesic drug. It is now under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential, although little more information is available.
n3:group
experimental illicit
n3:indication
Dimethylthiambutene is an opioid analgesic previously used in moderate pain relief.
owl:sameAs
n7:DB01444 n10:DB01444
dcterms:title
Dimethylthiambutene
adms:identifier
n9:Dimethylthiambutene n11:46505069 n12:DB01444 n13:10668 n14:59781 n15:10218
n3:synonym
Dimethibutin Ohton
n3:IUPAC-Name
n4:271B4BC0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4BC6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4BC5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4BC2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4BC3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4BC4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4BBE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4BBC-363D-11E5-9242-09173F13E4C5 n4:271B4BBF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4BBD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4BCC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4BCD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4BC7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4BC8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4BCA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4BC9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4BCB-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
524-84-5
n3:Bioavailability
n4:271B4BD1-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B4BD6-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4BD3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4BD4-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4BD5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4BD0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4BCF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4BD2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4BC1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4BCE-363D-11E5-9242-09173F13E4C5